Brief: CMA Says Court Of Appeal Ruled Tribunal Was "Wrong To Set Aside Decision" In Relation To Investigation Into Phenytoin
BRIEF-CMA Says Court Of Appeal Ruled Tribunal Was "Wrong To Set Aside [CMA's] Decision" In Relation To Investigation Into Phenytoin June 19 (Reuters) - UK's CMA:
UK'S CMA: COURT OF APPEAL HAS RULED TRIBUNAL WAS "WRONG TO SET ASIDE [CMA'S] DECISION" IN RELATION TO ITS INVESTIGATION INTO PHENYTOIN
CMA: COURT TO CONSIDER FURTHER SUBMISSIONS FROM PARTIES BEFORE DECIDING WHETHER TO REINSTATE CMA'S DECISION, INCLUDING FINES
Source text: [ID:]
Further company coverage: PFE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials